Skip to main navigation

IR Nav

Investors Stock

Stock Quote/Chart Analyst Coverage

News & Events

News Releases Investor Calendar

Financials

SEC Filings Quarterly Results

Governance

Corporate Governance Committee Composition

Investor Resources

Investor FAQs Email Alerts Contact IR

IR Nav

Investors Stock

Stock Quote/Chart Analyst Coverage

News & Events

News Releases Investor Calendar

Financials

SEC Filings Quarterly Results

Governance

Corporate Governance Committee Composition

Investor Resources

Investor FAQs Email Alerts Contact IR

Investor Calendar

Investor Calendar

Past Events

Intelligent Bio Solutions Inc. First Quarter 2023 Financial Results

November 09, 2022 at 4:30 PM EST

Click here for Webcast

GBS, Inc. Fourth Quarter 2022 Financial Results Conference Call

August 31, 2022 at 4:30 PM EDT

Click here for Webcast

GBS, Inc. Virtual 2022 Annual Shareholder Meeting

June 16, 2022 at 4:00 PM EDT

Virtual Meeting Link

H.C. Wainwright Global Investment Conference

May 24, 2022 at 7:00 AM EDT

Webcast & Registration Link

GBS, Inc. Third Quarter 2022 Financial Results Conference Call

May 10, 2022 at 4:30 PM EDT

Click here for Webcast

Maxim Virtual Growth Conference

03/28 - 03/30/22

Click here for Webcast

34th Annual Roth Conference

March 15, 2022 at 11:00 AM EDT

GBS, Inc. Second Quarter 2022 Financial Results Conference Call

February 10, 2022 at 4:30 PM EST

Click here for Webcast

H.C. Wainwright BioConnect Virtual Conference

01/10 - 01/13/22

Registration Link

11th Annual LifeSci Partners Corporate Access Event

01/05 - 01/07/22

Registration Link

GBS Inc: A Saliva Test for Diabetes Monitoring: An inside look at the Glucose Biosensor Technology

November 15, 2021

Click here for Podcast

GBS, Inc. First Quarter 2022 Financial Results

November 11, 2021 at 4:30 PM EST

Click here for Webcast

Benzinga Healthcare Small Cap Conference

September 29, 2021 at 4:20 PM EDT

Click here for Webcast

H.C. Wainwright 23rd Annual Global Investment Conference

September 13, 2021 at 7:00 AM EDT

GBS,Inc. Fourth Quarter 2021 and Full Year Financial Results Conference Call & Webcast

August 11, 2021 at 4:30 PM EDT

Listen to Webcast

Legal

Privacy Policy Disclaimer Terms of Use

Social icons

twitter linkedin

Certain statements in this website may constitute “forward-looking” statements as defined in Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), Section 21E of the Securities Exchange Act of 1934 (the “Exchange Act”), the Private Securities Litigation Reform Act of 1995 (the “PSLRA”) or in releases made by the Securities and Exchange Commission (“SEC”), all as may be amended from time to time. Such forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievements of IBS, Inc. and its affiliates (“IBS”) or industry results, to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. Statements that are not historical fact are forward-looking statements. Forward-looking statements can be identified by, among other things, the use of forward-looking language, such as the words “plan,” “believe,” “expect,” “anticipate,” “intend,” “estimate,” “project,” “may,” “will,” “would,” “could,” “should,” “seeks,” or “scheduled to,” or other similar words, or the negative of these terms or other variations of these terms or comparable language, or by discussion of strategy or intentions. These cautionary statements are being made pursuant to the Securities Act, the Exchange Act and the PSLRA with the intention of obtaining the benefits of the “safe harbor” provisions of such laws.

IBS cautions that any forward-looking statements made by IBS are not guarantees or indicative of future performance. Although IBS believes that its plans, cost estimates, returns on investments, intentions and expectations reflected in or suggested by such forward-looking statements are reasonable, actual results could differ materially from a projection or assumption in any forward-looking statements. IBS’s future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties. IBS does not have, or undertake, any obligation to update or revise any forward-looking statements whether as a result of new information, subsequent events or otherwise, unless otherwise required by law.

These materials are not intended as an offer or solicitation with respect to the purchase or sale of any security and may not be reproduced or redistributed in whole or in part to any other person. Recipients should seek appropriate independent professional advice prior to relying on, or entering into any commitment based upon materials.

All information included in this website is based on continuing operations, unless otherwise noted.

© Copyright 2023 Intelligent Bio Solutions Inc. All rights reserved.